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Objective: To compare the frequency of prolonged QTc interval in cirrhotics with non-cirrhotics having chronic 
liver disease.  
Study design: Cohort study. 
Place and Duration of Study: Department of Gastroenterology AK CMH/Sheikh Khalifa Bin Zayed Al Nahyan 
Hospital Rawalakot Azad Kashmir. Six months; (27-03-2019 to 26-09-2019). 
Material and Methods: One hundred patients with liver cirrhosis (group I) and 100 non-cirrhotic patients ((group 
II) had 12 lead ECGs. QT interval was calculated. And the patients were evaluated for the presence of prolonged 
QT interval.  Statistical significant determined by chi-square test (p< 0.05 was taken as significant).   
Results: The mean QTc duration in Group I was 0.536 + 0.012 seconds and group II was 0.431 + 0.015 seconds (p 
< 0.05). Prolonged QTc interval was present among 36(36%) patients in Group I and 6 (6%) patients in Group II. (p 
< 0.05).  
Conclusion: Our study findings revealed that cirrhotic patients have more chances of developing the QTc 
abnormalities as compared to the patients without the presence of cirrhotic liver. 
Keywords: Cirrhosis; cardiomyopathy; prolonged QTc interval. 




Liver cirrhosis (LC) is a late stage of progressive 
hepatic fibrosis is characterized by distortion of the 
architecture and formation of regenerative nodules 
and different degrees of liver function impairment; 
these patients are prone to a variety of complications 
reducing life expectancy markedly.1 
The World Health Organization (WHO) indicates that 
10% of the world's population has chronic liver 
disease. 2 Liver cirrhosis is an epidemic in Pakistan 
due to the very high prevalence of Hepatitis B and C 
in our community. Hepatitis C is the leading cause of 
Cirrhosis in Pakistan.3  
Approximately 10 million peoples have been infected 
with Hepatitis C infection in Pakistan.4 It is estimated 
that 3% of the world's population has been infected 
with Hepatitis C infection. The prevalence of hepatitis 
C in Pakistan is 4-6%.5 
In the evolution of many chronic liver diseases, 
cirrhosis is a stage that is considered to be irreversible. 
The most common complications of cirrhosis are 
gastrointestinal hemorrhage, ascites, encephalopathy, 
bacterial infections, renal failure, hepatocellular 
carcinoma, and hepatic failure. Certain reversible 
components of cirrhosis have been indicated where 
significant histological improvement has occurred 
with regression of cirrhosis but complete resolution 
with a return to normal architecture seems unlikely.6 
The underlying immunological response has usually 
been acting for months or years where inflammation 
and tissue repairing are in progress simultaneously 
which leads in the end to fibrosis and cirrhosis.7 
The main causes of cirrhosis are alcoholic liver disease 
(ALD), hepatitis B (HBV), hepatitis C (HCV), non-
alcoholic steatohepatitis (NASH), haemochromatosis, 
auto-immune hepatitis (AIH), primary biliary cirrhosis 
(PBC), and primary sclerosing cholangitis (PSC).8 The 
natural history of cirrhosis can be divided into a 
preclinical and a subsequent clinical phase. The 
preclinical phase is usually prolonged over several 
years; once clinical events occur, such as ascites, 
encephalopathy, variceal bleeding, or the development 
of hepatocellular carcinoma the remaining course of 
the disease is much shorter and usually fatal.9 
Liver cirrhosis is associated with different 
cardiovascular abnormalities called cirrhotic 
cardiomyopathy which is defined as the constellation 
of one or more of the following changes:  
1. normal or augmented systolic function at rest 
but blunted contractile responsiveness to 
stress,  
2. altered diastolic relaxation,  
3. structural abnormalities in the cardiac 
chambers, and 
4. electrophysiological changes such as 
prolonged QT. 10-12 
The QT interval is a measure of ventricular electrical 
recovery after excitation.13 Acquired QTc prolongation 
has been described in association with cardiac 
diseases, electrolyte abnormalities (such as 
hypocalcemia, hypomagnesemia, and hypokalemia), 
and many commonly used drugs. Prolonged QTc may 
provide the substrate for ventricular arrhythmias. 
14,15,16 Cirrhotic cardiomyopathy may play a role in the 
pathogenesis of the hepatorenal syndrome.17,18 It is a 
new entity and very little work has been done in 
Pakistan. Exact data is lacking in our population and 
my study will help in the early detection of cardiac 
abnormalities, which will help better management and 
also the risk of sudden cardiac death in cirrhotic 
patients. 
 
Materials and Methods 
 
This cohort study was conducted at the Department of 
Gastroenterology AK CMH/Sheikh Khalifa Bin Zayed 
Al Nahyan Hospital Rawalakot Azad Kashmir for six 
months after the approval from the hospital ethical 
committee (27/03/19 to 26/09/19). A sample size of 
200 cases (100 in each group) was calculated with 80% 
power of the test, 1% level of significance, and taking 
an expected percentage of QTc abnormality in both 
groups i.e. 37% in patients with cirrhosis versus 5.9% 
in non-cirrhotics having chronic liver disease. The non-
probability purposive sampling technique was used to 
gather the sample. Patient from 18 to 70 years of age 
from both genders who had cirrhosis of liver proved 
(by ultrasound by Radiology department of AK 
CMH/Sheikh Khalifa Bin Zayed Al Nahyan Hospital 
Rawalakot Azad Kashmir), were placed in Group I, 
and patient having HCV positive (by pathology 
department of AK CMH/Sheikh Khalifa Bin Zayed Al 
Nahyan Hospital Rawalakot Azad Kashmir) but had 
not developed cirrhosis (by ultrasound by Radiology 
department of AK CMH/Sheikh Khalifa Bin Zayed Al 
Nahyan Hospital Rawalakot Azad Kashmir) were 
placed in Group II. Patients with HTN, IHD and 
taking cardio-selective drugs such as B-Blockers, Ca 
channel blockers, anti-arrhythmic and cardiac 
glycosides (assessed on patient history) and those with 
conduction defect on ECG or those with valvular heart 
disease and heart failure on Echocardiography were 
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excluded from the study Hyperkalemic patients were 
also not included in the study. 
100 patients with cirrhosis of the liver (Group-1) and 
100 non-cirrhotic patients (Group-II) were enrolled 
from the Department of Gastroenterology AK 
CMH/Sheikh Khalifa Bin Zayed Al Nahyan Hospital 
Rawalakot Azad Kashmir. After informed consent, 
patients’ demographic details like name, age, the sex 
were recorded. Every patient had three ECGs by the 
same ECG machine (Nihon Kohden Cardiolife), which 
was used for taking mean QTc interval for each 
patient, and all the ECGs were interpreted by the same 
observer following standard criteria to avoid observer 
bias for detection of prolonged QTc interval. Data was 
entered on the specifically designed study proforma. 
Data was entered and analyzed by using the Statistical 
Package for Social Sciences version 23.0. The 
qualitative data like gender and prolonged QTc were 
presented as frequency distribution and quantitative 
data like age (in years) were presented as mean ± SD. 
Comparison of prolonged QTc interval in Cirrhotics 
and non-Cirrhotics was done by Chi-square test. P-




Two hundred patients were included in this study. 
Each group had 100 patients. The mean age of the 
patients in Group I was 40.22 ± 10.66 years [range 19 – 
68]. There were 7 (7%) patients of the age range of 18 - 
30 years, 13 (13%) patients of the age range of 31 – 40 
years, 39 (39%) patients of the age range of 41- 50 
years, 32 (32 %) patients of the age range of 51 – 60 
years and 9 (9%) patients of the age range of 61 – 70 
years. The mean age of the patients in Group II was 
37.81 ± 10.58 years [range 20 – 69]. There were 11 
(11%) patients of the age range of 20 - 30 years, 24 
(24%) patients of the age range of 31 – 40 years, 29 
(29%) patients of the age range of 41- 50 years, 24 
(24%) patients of the age range of 51 – 60 years and 12 
(12%) patients of the age range of 61 – 70 years. There 
were 55 (55%) female patients in Group I and 34 (34%) 
in Group II. Similarly, there were 55 (55%) male 
patients in Group I and 67 (67%) patients in Group II. 
The mean QTc duration in Group I was 0.536 + 0.012 
seconds and Group II was 0.431 + 0.015 seconds. The 
results were statistically significant (p-value < 0.05) 
(Table 1).  Prolonged QTc interval was present among 
36 (36%) patients in Group I and 6 (6%) patients in 
Group II. QTc interval was not prolonged among 64 
(64%) patients in Group I and in 94 (94%) patients in 
Group II. The results were statistically significant (p < 
0.05) (Table 2). 
 
Table 1: Distribution of patients based on QTc 




Group I Group II 
Mean + SD  Mean + SD 
0.536 + 0.012 0.431 + 0.015 
p-value 0.001** 
 





Group I Group II p-
value* No. % No. % 
Yes 36 36 8 6 0.000*
* No 64 64 92 94 




Cardiovascular changes among cirrhotic patients are 
not infrequent which is not diagnosed routinely 
because of relative unawareness regarding this entity. 
It has many features including prolongation of QTc, 
increased HR, decreased myocardial contraction force, 
and diastolic dysfunction. Prolonged QTc interval was 
a common finding in our study, which was present 
more frequently, i.e. 36% among cirrhotic patients as 
compared to 6% in non-cirrhotic patients (p < 0.05).  
Previously, a study was carried out by Ahmad U, et al. 
69 including 100 patients. The mean age in both 
groups was 38.2 years and 37.4 years. Like our study, 
male patients dominated the female population. The 
mean ± SD of QTc on Group-I was 0.472 ± 0.012 sec 
and that in Group-II was 0.434 ±0.014 sec. Like our 
study, they also observed prolongation of the QTc 
interval. The criterion for prolonged QTc interval was 
≥ 0.440 sec.  
Zuberi BF, et al.18 also conducted a study to compare 
the cardiovascular changes among cirrhotic with non-
cirrhotic patients. The mean ± SD of QTc among 
cirrhotic patients was 0.438 ± 0.015 sec and that in non-
cirrhotic was 0.432 ±0.010 sec (p < 0.05).   The 
frequency of prolonged QTc interval (i.e. > 0.44 sec) 
was seen among 19.2% of patients in cirrhotic patients, 
while it was 5.1% among non-cirrhotic patients. The 
results were statistically significant (p=0.014). These 
observations were also similar to that of the study i.e. 
higher frequency of prolonged QTc interval was 
observed among cirrhotic patients as compared to 
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non-cirrhotics. Tarique S, et al.70 studied 117 patients 
with liver cirrhosis and determined that 52.1% of 
patients had prolonged QTc intervals with a mean of 
0.425 + 0.053 seconds.  
Trevisani F, et al. 71 reviewed the clinical records of 70 
consecutive cirrhotic and 40 non-cirrhotic patients 
with acute gastrointestinal bleeding. They observed a 
lengthened QTc at the time of bleeding, 453.4 ± 4.3 ms 
in cirrhotics; contrariwise while QTc did not change in 
non-cirrhotic patients. The studies have shown that the 
QTc interval may be prolonged among the cirrhotic 
population. However, there remains a question about 
its clinical significance. Prolongation of QTc duration 
can also be used as a non-invasive and rapid 
diagnostic marker of cirrhotic cardiomyopathy as was 
proved in the study conducted by Zubairi BF, et al.18  
Prolongation of QTc interval is useful for assessment 
of the severity of chronic liver disease by Arikan C, et 
al.22 However, this has been negated by Tarique S, et 
al.20  Zamirian M, et al.23 showed that prolonged QTc 
interval improves with the liver transplantation 
suggesting that liver cirrhosis has independently 
unfavorable, but reversible electrophysiological 
effects. 
This study had some limitations. This was a single-
center study with limited population size. This was not 
a double-blind study. However, we did randomization 





In conclusion, this study concluded that the 
prolongation of the QTc interval is seen among 
cirrhotic patients as compared to non-cirrhotic 
patients. So, it is recommended that every patient 
diagnosed with liver cirrhosis should have a routine 12 
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